The biological activity and activation of 15,16-dihydro-1,11-methanocyclopenta[a]phenanthren-17-one, a carcinogen with an obstructed bay region.
The proposal that an unobstructed bay region is a prerequisite for tumorigenic activity in cyclopenta[a]phenanthrene-17-ones is not supported by the observation of the tumorigenicity of 15,16-dihydro-1,11-methanocyclopenta[a]phenanthrene-17-one towards the skin of T.O. mice. The title compound is oxidised in vitro by a mixed function oxidase to produce, inter alia, a trans-3,4-dihydrodiol, postulated as the proximate tumorigen. Unequivocal identification of a second metabolite as a trans-1,2-dihydrodiol derivative demonstrates the potential for enzymatic oxidation within the obstructed bay region and supports the proposal that the ultimate tumorigen is a trans-3,4-dihydrodiol-anti-1,2-oxide. This is further substantiated by the chromatographic behaviour of the major hydrocarbon-nucleoside adduct derived from mouse skin treated with the parent compound in vivo. The structures of certain others of the metabolites produced in vitro are also considered.